Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Gating
1 other identifier
observational
12
1 country
1
Brief Summary
Objectives: Evaluation of an amplitude based gated Positron Emission Tomography (PET) data acquisition system for all GE Discovery Positron Emission Tomography/ Computed Tomography (PET/CT) scanners.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2009
CompletedFirst Posted
Study publicly available on registry
February 13, 2009
CompletedStudy Start
First participant enrolled
March 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedFebruary 17, 2016
January 1, 2012
2.8 years
February 12, 2009
February 15, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean Difference Between Gated + Ungated PET/CT Scans
Scheduled PET/CT scans extended by 10 minutes
Study Arms (1)
PET/CT Scan
Interventions
PET/CT scan performed with elastic belt around lower chest/upper abdomen to track breathing motion.
Eligibility Criteria
Individuals over the age of 18 with non-small cell lung cancer (NSCLC) and are scheduled to have a positron emission tomography/computed tomography (PET/CT) scan.
You may qualify if:
- Patients with lung or liver lesions measuring 0.5-2cm in diameter will be considered.
- Patients that are scheduled to be imaged in the PET/CT suite at the Mays Building will only be considered.
You may not qualify if:
- Pediatric patients (younger than 18 years) will be excluded.
- Patients that cannot tolerate being scanned for an additional 10 minutes with arms above their head will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- GE Healthcarecollaborator
Study Sites (1)
UT MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Osama R Mawlawi, PHD
UT MD Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2009
First Posted
February 13, 2009
Study Start
March 1, 2009
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
February 17, 2016
Record last verified: 2012-01